TheraBiologics

TheraBiologics Overview

Founded 2011
Founded
Status Private
Latest Deal Type Grant
Latest Deal Amount $28M
Latest Deal Amount
Investors 1

TheraBiologics General Information

Description

Developer of stem cell mediated cancer therapies designed to help patients recover cancer. The company's stem cell mediated cancer therapies develops human neural stem cell to provide anti-cancer agents that are specific to invasive cancer sites in order to maximize therapeutic concentrations of the targeted disease and minimize off target toxicities, enabling doctors to treat cancers and help patients recover the same.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • 2221 Highland Oaks Drive
  • Arcadia, CA 91006
  • United States
+1 (626) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TheraBiologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant $28M Completed Startup
1. Angel (individual) 30-Jul-2012 Completed Startup

TheraBiologics Executive Team (2)

Name Title Board Seat Contact Info
Karen Aboody MD Co-Founder, Board Member & Chief Scientific Officer
Alexander Annala Ph.D Co-Founder, Chief Operating Officer, Chief Financial Officer, Chief Executive Officer & Board Member

TheraBiologics Board Members (1)

Name Representing Role Since
Alexander Annala Ph.D TheraBiologics Co-Founder, Chief Operating Officer, Chief Financial Officer, Chief Executive Officer & Board Member 000 0000

TheraBiologics Investors (1)

To view TheraBiologics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Regenerative Medicine Government 000 0000 000000 0

Ready to get started?

Request a free trial